T1	Participants 66 81	type 2 diabetes
T2	Participants 879 923	8 patients, 5 of whom were insulin-requiring
T3	Participants 1391 1406	normal subjects
T4	Participants 1767 1794	normal nondiabetic subjects
T5	Participants 572 668	type 2 diabetes subjects whose diabetes was relatively mild in terms of therapeutic requirements
